Aardvark’s next move after clinical hold; Alumis’ verdict on Acelyrin assetnews2026-05-15T14:22:19+00:00May 15th, 2026|Endpoints News|
M&A isn’t just for big pharma. Mid-size companies are stepping up deal huntsnews2026-05-15T12:43:17+00:00May 15th, 2026|Endpoints News|
Andrea Pfeifer ends 23-year reign at AC Immune; Acadia’s top R&D exec announces retirementnews2026-05-15T11:00:01+00:00May 15th, 2026|Endpoints News|
#ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes livenews2026-05-15T10:45:33+00:00May 15th, 2026|Endpoints News|
